Drug Interactions between Austedo XR and Truseltiq
This report displays the potential drug interactions for the following 2 drugs:
- Austedo XR (deutetrabenazine)
- Truseltiq (infigratinib)
Interactions between your drugs
No interactions were found between Austedo XR and Truseltiq. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Austedo XR
A total of 447 drugs are known to interact with Austedo XR.
- Austedo xr is in the drug class VMAT2 inhibitors.
- Austedo xr is used to treat the following conditions:
Truseltiq
A total of 206 drugs are known to interact with Truseltiq.
- Truseltiq is in the drug class multikinase inhibitors.
- Truseltiq is used to treat Biliary Tract Tumor.
Drug and food interactions
infigratinib food
Applies to: Truseltiq (infigratinib)
Infigratinib should be taken on an empty stomach, at least 1 hour before or 2 hours after food. Do not consume grapefruit, grapefruit juice, or any supplements that contain grapefruit extract during treatment with infigratinib unless directed otherwise by your doctor. Grapefruit juice can increase the blood levels of infigratinib. This may increase the frequency and severity of serious side effects such as infections; decreased red blood cell, white blood cell, and platelet counts; fever; abdominal pain; increased blood calcium and phosphate levels above normal; eye and vision problems; mouth sores and inflammation; diarrhea; redness, swelling, peeling or tenderness, mainly on the hands and feet ('hand-foot syndrome'); nails separating from the bed or poor formation of the nail; and changes in kidney function blood tests. Talk to your doctor if you have any questions or concerns. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.